CollPlant Biotechnologies (CollPlant Biotechnologies) Pretax Margin % : -4,280.61% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. CollPlant Biotechnologies's Pre-Tax Income for the three months ended in Mar. 2024 was $-4.20 Mil. CollPlant Biotechnologies's Revenue for the three months ended in Mar. 2024 was $0.10 Mil. Therefore, CollPlant Biotechnologies's pretax margin for the quarter that ended in Mar. 2024 was -4,280.61%.

The historical rank and industry rank for CollPlant Biotechnologies's Pretax Margin % or its related term are showing as below:

CLGN' s Pretax Margin % Range Over the Past 10 Years
Min: -9540.79 Med: -303.13 Max: 1.52
Current: -70.59

CLGN's Pretax Margin % is ranked better than
58.63% of 1025 companies
in the Biotechnology industry
Industry Median: -154.52 vs CLGN: -70.59

CollPlant Biotechnologies Pretax Margin % Historical Data

The historical data trend for CollPlant Biotechnologies's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Pretax Margin % Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

Get a 7-Day Free Trial

-481.62

-94.09

1.52

-5,660.54

-64.05

CollPlant Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pretax Margin %	Get a 7-Day Free Trial															-857.97	56.58	-10,179.07	-1,568.23	-4,280.61

Competitive Comparison of CollPlant Biotechnologies's Pretax Margin %

For the Biotechnology subindustry, CollPlant Biotechnologies's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Pretax Margin % falls into.

CollPlant Biotechnologies Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

CollPlant Biotechnologies's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-7.019	/	10.959
	=	-64.05 %

CollPlant Biotechnologies's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4.195	/	0.098
	=	-4,280.61 %

CollPlant Biotechnologies (NAS:CLGN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

CollPlant Biotechnologies Pretax Margin % Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.